NewsBenzingaOppenheimer mantiene il rating Outperform su BridgeBio Oncology, abbassa il prezzo obiettivo a 16 dollari Oppenheimer mantiene il rating Outperform su BridgeBio Oncology, abbassa il prezzo obiettivo a 16 dollari Benzinga 2026.10.20 18:12 (GMT+0) Open on Benzinga Other news United Airlines Expects Q4 Unit Revenue Growth To Accelerate Versus Q3; Unit Cost Excluding Fuel Growth Is Expected To Step Down For Q4 Versus Q3; For Q4, Co. Assumes An All-In Avg Fuel Price Per Gallon Of About $4.80 Based On Gulf Coast Jet Forward... SpaceX Delivers Q3 Double Beat as AI Revenue Soars Neptune Insurance Hldgs Raises FY2026 Sales Guidance from $199.000M to $204.000M vs $202.142M Est TechnipFMC Signs MOU With BP Plc’s Subsidiary BP Exploration & Production For 20K Subsea Tree Systems For Paleogene Projects In Gulf Of America Netflix Will Introduce Advertising Tier To 15 New Countries In 2027; Adjusted Expected 2026 FCF Forecast To ~$12B Vs. Prior Projection Of $12.5B United Airlines Stock Sinks After Q3 Results Miss Estimates
United Airlines Expects Q4 Unit Revenue Growth To Accelerate Versus Q3; Unit Cost Excluding Fuel Growth Is Expected To Step Down For Q4 Versus Q3; For Q4, Co. Assumes An All-In Avg Fuel Price Per Gallon Of About $4.80 Based On Gulf Coast Jet Forward...
TechnipFMC Signs MOU With BP Plc’s Subsidiary BP Exploration & Production For 20K Subsea Tree Systems For Paleogene Projects In Gulf Of America
Netflix Will Introduce Advertising Tier To 15 New Countries In 2027; Adjusted Expected 2026 FCF Forecast To ~$12B Vs. Prior Projection Of $12.5B
